Caroline Mosessian
Fortuna: - $ al 31/08/2024
Fortuna: - $ al 31/08/2024
Caroline Mosessian is the founder of Innovative Strategies & Solutions, Inc. Dr. Mosessian currently holds the position of Director & Chief Regulatory Officer at Vitro Biopharma, Inc. since 2023.
Dr. Mosessian is also an Associate Professor at the University of Southern California.
Dr. Mosessian completed graduate and doctorate degrees at the University of Southern California.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 29/01/2024 | 0 ( -.--% ) | - $ | 31/08/2024 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VITRO DIAGNOSTICS, INC. | Director/Miembro de la Junta | 01/02/2021 |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
Innovative Strategies & Solutions, Inc. | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Vitro Biopharma, Inc.
Vitro Biopharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops cell therapies for autoimmune diseases and inflammatory disorders | Health Technology |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innovative Strategies & Solutions, Inc. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.